She has a degree in Pharmaceutical Sciences and graduated in 1998 from the Central University of Las Villas. She completed her doctoral training in immunopharmacological issues, obtaining in 2006 the degree of Dr. in Pharmaceutical Sciences. She has been a Principal Investigator since 2015. She served as Director of Research and is currently the Vice Director of Research and Development at the Finlay Vaccine Institute. She has received the Cuban Academy of Sciences Award and the Annual Health Award several times. She has published more than 30 scientific articles in high-impact factor journals in recent years. She has participated in the most recognized national and international events on vaccines. She has been one of the leading investigators of the pneumococcal conjugate vaccine development project and the Soberana vaccines. She has represented Cuba and the Institute in various events, expert committees, and meetings of the WHO, UNICEF, and ICG. In 2019, she received the Carlos J. Finlay Award, the highest recognition for Cuban scientists.
- What type of manufacturing capabilities need to be established to take ownership of vaccine production and distribution within the region?
- Adopting and innovating new tech to enhance self-reliance and reduce dependency on global supply chains
- The importance of strategic regional partnerships; addressing challenges in knowledge transfer, and building sustainable local expertise in vaccine production
- Strategies for creating a sustainable and resilient vaccine manufacturing ecosystem
- Examination of the regulatory frameworks governing vaccine manufacturing in LATAM; Challenges in harmonizing regulations across the region to streamline manufacturing processes